Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Frostman who wrote (10161)	6/27/1998 8:03:00 PM
From: RT	Respond to of 23519

Frostman, I believe you posted that article earlier. At this point I don't know if Viagara's sales slump will have any impact on Muse. Muse scripts appear to have leveled off but the Viagara effect has failed to materialize. (SO FAR). Have you been reading the Yahoo board? BigScane works for Vivus and according to him the plants are operating at full tilt. The old plant is operating it's two lines 24 hrs. 7 days a week, with mandatory overtime. The new plant is operating 4 lines full tilt since around the 22 of June. Major product backlog according to him. All production is being shipped. With world markets opening up we may someday emerge from this stink pile smelling like roses. Wouldn't that be a blessing? I firmly believe the June 29 meeting will jump start the Vivus recovery. Hang in their buddy, the pot of gold is just around the corner. RT PS. Jack W. Garnes Jr. need not respond to this post unless you have something positive to add. <<gg>>